New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - risperidone 0.5mg;   - film coated tablet - 0.5 mg - active: risperidone 0.5mg   excipient: hyprolose hypromellose iron oxide red lactose monohydrate macrogol 8000 magnesium stearate maize starch microcrystalline cellulose titanium dioxide - apo-risperidone is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - risperidone 1mg;   - film coated tablet - 1 mg - active: risperidone 1mg   excipient: hyprolose hypromellose lactose monohydrate macrogol 8000 magnesium stearate maize starch microcrystalline cellulose titanium dioxide - apo-risperidone is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - risperidone 2mg;   - film coated tablet - 2 mg - active: risperidone 2mg   excipient: hyprolose hypromellose lactose monohydrate macrogol 8000 magnesium stearate maize starch microcrystalline cellulose sunset yellow aluminium lake titanium dioxide - apo-risperidone is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - risperidone 3mg;  ;   - film coated tablet - 3 mg - active: risperidone 3mg     excipient: hyprolose hypromellose iron oxide yellow lactose monohydrate macrogol 8000 magnesium stearate maize starch microcrystalline cellulose titanium dioxide   - apo-risperidone is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - risperidone 4mg - film coated tablet - 4 mg - active: risperidone 4mg excipient: hyprolose hypromellose indigo carmine iron oxide red lactose monohydrate macrogol 8000 magnesium stearate maize starch microcrystalline cellulose titanium dioxide - apo-risperidone is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - risperidone 1 mg/ml - oral solution - 1 mg/ml - active: risperidone 1 mg/ml excipient: benzoic acid purified water sodium hydroxide sorbitol tartaric acid - apo-risperidone is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent. apo-risperidone also alleviates affective symptoms (such as depression, guilt-feelings, anxiety) associated with schizophrenia. in addition, apo-risperidone also appears effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial response to treatment with this agent.

Malta - English - Medicines Authority

accord healthcare limited - risperidone - film-coated tablet - risperidone 0.5 mg - psycholeptics

Malta - English - Medicines Authority

accord healthcare limited - risperidone - film-coated tablet - risperidone 1 mg - psycholeptics

Malta - English - Medicines Authority

accord healthcare limited - risperidone - film-coated tablet - risperidone 2 mg - psycholeptics

Malta - English - Medicines Authority

accord healthcare limited - risperidone - film-coated tablet - risperidone 3 mg - psycholeptics